We use AI to screen existing FDA-approved drugs as potential treatments for neglected diseases — illnesses that affect over 1 billion people but receive almost no pharmaceutical investment. Our findings are published freely for researchers worldwide.
Latest Results — February 28, 2026
🏆 Ivermectin vs Malaria (Falcipain-2): -10.21 kcal/mol — EXCEPTIONAL
🔥 Imatinib vs Malaria (Falcipain-2): -9.887 kcal/mol — EXCELLENT
✅ Ivermectin vs Chagas (Cruzain): -7.262 kcal/mol — STRONG HIT
✅ Imatinib vs Sleeping Sickness (TbCatB): -7.711 kcal/mol — STRONG HIT
✅ Niclosamide vs Malaria: -7.820 kcal/mol — STRONG HIT
Threshold for drug interest: -6.0 kcal/mol. All top candidates exceed it.
Built by Stephen Salone + Nova (AI) + Grok (AI) — Day 1.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.